These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8989237)

  • 1. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.
    Lakatos P; Foldes J; Horvath C; Kiss L; Tatrai A; Takacs I; Tarjan G; Stern PH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):78-81. PubMed ID: 8989237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A; Colak O; Alatas O; Efe B
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
    Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin and bone metabolism markers in hyperthyroidism before treatment and interrelations between them.
    Sarıtekin İ; Açıkgöz Ş; Bayraktaroğlu T; Kuzu F; Can M; Güven B; Mungan G; Büyükuysal Ç; Sarıkaya S
    Acta Biochim Pol; 2017; 64(4):597-602. PubMed ID: 29059259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of bone turnover in hyperthyroidism and the effects of treatment.
    Garnero P; Vassy V; Bertholin A; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokines and bone metabolism in patients with thyroid dysfunction.
    Sekeroglu MR; Altun ZB; Algün E; Dülger H; Noyan T; Balaharoglu R; Oztürk M
    Adv Ther; 2006; 23(3):475-80. PubMed ID: 16912030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum osteocalcin in hyperthyroidism].
    Roiter I; Legovini P; Da Rin G; Galliazzo S; Di Virgilio R; Foscolo G; Breda F; Conte N
    Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships existing between the serum cytokine levels and bone mineral density in women in the premenopausal period affected by Graves' disease with subclinical hyperthyroidism.
    Ugur-Altun B; Altun A; Arikan E; Guldiken S; Tugrul A
    Endocr Res; 2003 Nov; 29(4):389-98. PubMed ID: 14682468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone and calcium metabolism in subclinical autoimmune hyperthyroidism and hypothyroidism.
    Kisakol G; Kaya A; Gonen S; Tunc R
    Endocr J; 2003 Dec; 50(6):657-61. PubMed ID: 14709834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
    Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
    J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
    Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cytokines in thyrotoxicosis.
    Siddiqi A; Monson JP; Wood DF; Besser GM; Burrin JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism.
    Lee MS; Kim SY; Lee MC; Cho BY; Lee HK; Koh CS; Min HK
    J Clin Endocrinol Metab; 1990 Mar; 70(3):766-70. PubMed ID: 2307730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease.
    Yamada T; Sato A; Komiya I; Nishimori T; Ito Y; Terao A; Eto S; Tanaka Y
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2775-8. PubMed ID: 10946880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G; Karter Y; Aydin S; Uzun H
    Chin J Physiol; 2003 Dec; 46(4):181-6. PubMed ID: 15074839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and its considerable role in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in postmenopausal women.
    Mysliwiec J; Adamczyk M; Nikolajuk A; Gorska M
    Endokrynol Pol; 2011; 62(4):299-302. PubMed ID: 21879468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.